| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/23/2009 | CN101541788A Compounds and compositions as kinase inhibitors |
| 09/23/2009 | CN101541787A Process for the preparation of tertiary N-allyl sterically hindered amines |
| 09/23/2009 | CN101541786A Indoles which act as V1a receptor antagonists |
| 09/23/2009 | CN101541785A Substituted dihydropyrazolones and use thereof as HIF-prolyl-4 -hydroxylase inhibitors |
| 09/23/2009 | CN101541784A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 09/23/2009 | CN101541783A Pyridinonyl PDK1 inhibitors |
| 09/23/2009 | CN101541782A Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 09/23/2009 | CN101541781A Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 09/23/2009 | CN101538264A Novel method for preparing chiral sulphoxide compound |
| 09/23/2009 | CN101538263A 2-ureido-6-heteroaryl-3H-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| 09/23/2009 | CN101538246A Pyrimidine amide compounds as pgds inhibitors |
| 09/23/2009 | CN101538245A One-class pyridazinone compounds and preparation method and application thereof |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101537746A Heat resistance improver and reversible thermosensitive recording medium |
| 09/23/2009 | CN100543024C Novel hydantoin derivatives for the treatment of obstructive airway diseases. |
| 09/23/2009 | CN100543023C IR compound and organic electroluminescent device using the same |
| 09/22/2009 | US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) |
| 09/22/2009 | US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 09/22/2009 | US7592360 3-fluoro-piperidines as NMDA/NR2B antagonists |
| 09/22/2009 | US7592358 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 09/22/2009 | US7592357 Compounds |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7592347 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 09/22/2009 | US7592346 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 09/22/2009 | US7592340 Quinoxalines useful as inhibitors of protein kinases |
| 09/22/2009 | US7592338 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 09/22/2009 | US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2009 | US7592336 Hepatitis C virus inhibitors |
| 09/22/2009 | US7592332 Cytokine inhibitors |
| 09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/22/2009 | CA2333086C Cocaine receptor binding ligands |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/17/2009 | WO2009114677A1 Pyridazine derivatives as factor xia inhibitors |
| 09/17/2009 | WO2009114552A1 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| 09/17/2009 | WO2009113696A1 Crystal of benzimidazole compound |
| 09/17/2009 | WO2009113600A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112568A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors |
| 09/17/2009 | WO2009112550A1 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 09/17/2009 | WO2009112533A1 Substituted triazinylmethyl sulfonamides |
| 09/17/2009 | WO2009112523A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 09/17/2009 | WO2009112490A1 Sulfonamides as zap-70 inhibitors |
| 09/17/2009 | WO2009112461A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/17/2009 | WO2009112155A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 09/17/2009 | WO2009111997A1 A method for the preparation of dabigatran |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2007129195A3 4-pyrimidine-5-amino-pyrazole compounds |
| 09/17/2009 | US20090234138 Acyloxyalkyl carbamate prodrugs, methods |
| 09/17/2009 | US20090234129 Synthesis of nicotine derivatives from nicotine |
| 09/17/2009 | US20090234127 Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives |
| 09/17/2009 | US20090233967 Crystalline forms of mc4r agonist and process for synthesis |
| 09/17/2009 | US20090233965 Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive Bladder |
| 09/17/2009 | US20090233956 NOVEL PYRROLO(2,3-b) PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS |
| 09/17/2009 | US20090233950 Quinazoline derivatives |
| 09/17/2009 | US20090233944 Pyrazine-2-carboxyamide derivatives |
| 09/17/2009 | US20090233943 New compounds 835 |
| 09/17/2009 | US20090233930 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia |
| 09/17/2009 | US20090233929 Imidazole Derivatives for the Treatment of Anxiety and Related Diseases |
| 09/17/2009 | US20090233928 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation |
| 09/17/2009 | US20090233924 Quinazoline derivatives |
| 09/17/2009 | US20090233908 Nitrogenous heterocyclic compound and medicinal use thereof |
| 09/17/2009 | US20090233897 Potassium Channel Inhibitors |
| 09/17/2009 | US20090233896 Inhibitors of checkpoint kinases |
| 09/17/2009 | US20090232328 Digital sound processing system for a vehicle |
| 09/17/2009 | DE102008013587A1 Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung Heteroaryl substituted dicyanopyridines and their use |
| 09/17/2009 | CA2718393A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | CA2718241A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/17/2009 | CA2717529A1 Sulfonamides as zap-70 inhibitors |
| 09/17/2009 | CA2717326A1 Preparation of lenalidomide |
| 09/17/2009 | CA2716907A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100892A1 Preparation of pyridonecarboxylic acid antibacterials |
| 09/16/2009 | EP2100891A1 Inhibitors of tyrosine kinases |
| 09/16/2009 | EP2100890A1 Novel polynitrogenated systems as anti-hiv agents |
| 09/16/2009 | EP2100889A1 Method for preparing 3-halo-4, 5-dihydro-1h-pyrazoles |
| 09/16/2009 | EP2100881A1 Pyrimidyl- or pyridinylaminobenzoic acid derivatives |
| 09/16/2009 | EP2100879A1 Novel N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 09/16/2009 | EP2099784A2 1,5-diphenyl-3-pyridinylamino-1,5-dihydrioyrrolidin-2-ones as cb1 receptor modulators |
| 09/16/2009 | EP2099783A1 Bicyclic lactam factor viia inhibitors useful as anticoagulants |
| 09/16/2009 | EP2099782A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 09/16/2009 | EP2099781A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
| 09/16/2009 | EP2099780A1 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders |
| 09/16/2009 | EP2099779A1 Crystalline forms of aryl-substituted pyrazole-amide compounds |
| 09/16/2009 | EP2099778A2 Amido anti-viral compounds |
| 09/16/2009 | EP2099770A2 Pyridazinones and furan-containing compounds |
| 09/16/2009 | EP2099767A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof |
| 09/16/2009 | EP2099766A1 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 09/16/2009 | EP2099765A2 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 09/16/2009 | EP2099763A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 09/16/2009 | EP2099762A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099761A2 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099760A1 Antibacterial quinoline derivatives |